trending Market Intelligence /marketintelligence/en/news-insights/trending/KcSc8NeZBT8UbkTuVYYHtQ2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Bellus Health to undertake 1-for-3.6 share consolidation

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Bellus Health to undertake 1-for-3.6 share consolidation

Bellus Health Inc. will consolidate its common shares on a 1-for-3.6 basis, effective Aug. 19.

The move will reduce the company's outstanding common shares from about 159.1 million to about 44.2 million.

The Quebec-based biopharmaceutical company expects trading in its post-consolidated shares to begin by Aug. 19 on the Toronto Stock Exchange under existing ticker BLU.

No fractional common shares will be issued in connection with the consolidation that was approved by the company's shareholders May 8.

Bellus Health's transfer agent, Computershare Investor Services, would act as the exchange agent for the consolidation.